Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen

被引:2
|
作者
Vokurka, Samuel [1 ]
Svoboda, Tomas [1 ]
Karas, Michal [1 ]
Koza, Vladimir [1 ]
Jindra, Pavel [1 ]
Kazakov, Dmitry [2 ]
Boudova, Ludmila [2 ]
机构
[1] Univ Hosp, Dept Hematooncol, Plzen 30460, Pilsen, Czech Republic
[2] Univ Hosp, Dept Pathol, Plzen 30460, Pilsen, Czech Republic
来源
MEDICAL SCIENCE MONITOR | 2011年 / 17卷 / 09期
关键词
graft-versus-host disease; melphalan; allogeneic transplantation; oral; BONE-MARROW; MELPHALAN; FLUDARABINE; RECIPIENTS;
D O I
10.12659/MSM.881933
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Oral graft-versus-host disease (GVHD) is a significant complication after allogeneic stem cell transplantation (SCT) and there is no consistent information about its characteristics in patients after reduced-intensity conditioning regimen FLU/MEL (fludarabine 12(1 mg/m(2) and melphalan 140mg/m(2)). Material/Methods: This was a single-centre prospective observational study of patients after allogeneic SCT with FLU/MEL conditioning performed during the period 1/2005-12/2007. Characteristics of oral GVHD were observed in 71 patients. The observation was discontinued due to death, donor lymphocyte infusion (DLI) or new chemotherapy administration. Results: In 10/2010, the median duration of the observation of the cohort of the patients was 13 (0.2-69) months, and 42 (35-69) months in the still-ongoing 20/71 (28%) patients. Oral acute GVHD had sporadic 7% incidence, whereas oral chronic GVHD was observed in 33% of patients and persisted with median duration of 188 (11-665) days. Clinical and histopathological features were similar in both acute and chronic oral GVHD and included mucosal lichenoid changes, erythema, ulcerations and pseudomembranes, satellite necrosis, apoptotic bodies and lichenoid interface inflammation. Conclusions: It is necessary to consider complex clinical symptomatology and pathological correlations when classifying the oral GVHD, because local oral symptoms and histopathological features in both acute and chronic oral GVHD forms can be similar. Even though the oral chronic GVHD was mild in the majority of patients, it can be considered as clinically significant due to its incidence, duration and symptomatology. The FLU/MEL conditioning regimen should not be considered as low-risk protocol in this context.
引用
收藏
页码:CR480 / CR484
页数:5
相关论文
共 50 条
  • [1] Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2
    Vokurka, S.
    Steinerova, K.
    Karas, M.
    Koza, V.
    BONE MARROW TRANSPLANTATION, 2009, 44 (09) : 601 - 605
  • [2] Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation
    Pérez-Simón, JA
    Díez-Campelo, M
    Martino, R
    Brunet, S
    Urbano, A
    Caballero, MD
    León, A
    Valcárcel, D
    Carreras, E
    del Cañizo, MC
    López-Fidalgo, J
    Sierra, J
    San Miguel, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (03) : 394 - 403
  • [3] Ocular Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
    Westeneng, Arnaud C.
    Hettinga, Ymkje
    Lokhorst, Henk
    Verdonck, Leo
    van Dorp, Suzanne
    Rothova, Aniki
    CORNEA, 2010, 29 (07) : 758 - 763
  • [4] Characteristics and risk factors of oral mucositis after allogeneic stem cell transplantation with FLU/MEL conditioning regimen in context with BU/CY2
    S Vokurka
    K Steinerova
    M Karas
    V Koza
    Bone Marrow Transplantation, 2009, 44 : 601 - 605
  • [5] Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease
    Robak, Katarzyna
    Zambonelli, Joanna
    Bilinski, Jaroslaw
    Basak, Grzegorz W.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (05) : 495 - 502
  • [6] MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation
    Tomuleasa, Ciprian
    Fuji, Shigeo
    Cucuianu, Andrei
    Kapp, Markus
    Pileczki, Valentina
    Petrushev, Bobe
    Selicean, Sonia
    Tanase, Alina
    Dima, Delia
    Berindan-Neagoe, Ioana
    Irimie, Alexandru
    Einsele, Hermann
    ANNALS OF HEMATOLOGY, 2015, 94 (07) : 1081 - 1092
  • [7] Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan
    Ritchie, DS
    Morton, J
    Szer, J
    Roberts, AW
    Durrant, S
    Shutttleworth, P
    Grigg, AP
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (07) : 435 - 442
  • [8] Microparticles for Diagnosis of Graft-Versus-Host Disease After Allogeneic Stem Transplantation
    Rank, Andreas
    Nieuwland, Rienk
    Toth, Bettina
    Pihusch, Verena
    Delker, Ruth
    Hiller, Erhard
    Kolb, Hans-Jochem
    Pihusch, Rudolf
    TRANSPLANTATION, 2011, 92 (02) : 244 - 250
  • [9] Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation
    Leithauser, M.
    Kahl, C.
    Aepinus, C.
    Prall, F.
    Maruschke, M.
    Riemer, H.
    Wolff, D.
    Jost, K.
    Hilgendorf, I.
    Freund, M.
    Junghanss, C.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (03) : 251 - 257
  • [10] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146